DuloxetineNayan Acharya, Ross J. Baldessarini, A. Rosen et al.|Journal of Clinical Psychopharmacology|2006Cited by 64
A phase 1 study of the Janus kinase 2 (JAK2)V617F inhibitor, gandotinib (LY2784544), in patients with primary myelofibrosis, polycythemia vera, and essential thrombocythemiaSrđan Verstovšek, Josef T. Prchal, Richard A. Walgren et al.|Leukemia Research|2017Cited by 41
Efficacy of Galcanezumab for Migraine Prevention in Patients With a Medical History of Anxiety and/or Depression: A Post Hoc Analysis of the Phase 3, Randomized, Double‐Blind, Placebo‐Controlled REGAIN, and Pooled EVOLVE‐1 and EVOLVE‐2 StudiesTodd A. Smitherman, Eric Pearlman, Vladimir Skljarevski et al.|Headache The Journal of Head and Face Pain|2020Cited by 35